> Watson Pharmaceuticals said Tuesday it will pay $36 million for a portfolio of generic drugs from rival Teva Pharmaceutical Industries, including a diabetes drug and an antidepressant, as that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results